NAVINFLUOR
532504Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of Equity Shares under Employees'' Stock Option Scheme 2017
Navin Fluorine International Ltd. is a leading specialty chemicals manufacturer headquartered in Mumbai, India, with a core focus on fluorine chemistry. Established as part of the Padmanabh Mafatlal Group, the company engages in the development, manufacturing, and export of a range of fluorochemicals, specialty chemicals, and contract research & manufacturing services (CRAMS).
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of Equity Shares under Employees'' Stock Option Scheme 2017
Announcement under Regulation 30 (LODR)-Credit Rating
Intimation of Revision in Credit Rating
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst Meet Intimation
Announcement under Regulation 30 (LODR)-Credit Rating
Intimation of Revision in Credit Rating
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earnings Call held for the quarter ended June 30, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results and Scrutinizer''s Report on e-voting - 28th AGM
Shareholder Meeting / Postal Ballot-Outcome of AGM
Summary of proceedings of the 28th Annual General Meeting of the Members of the Company.
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement of the Financial Results for Quarter ended June 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company's Earnings Call held today i.e. on August 05, 2026, regarding discussion on operational and financial performance for the quarter ended June 30, 2026 (Q1 of FY 2026-27) is available on the Company's website at https://www.nfil.in/uploads/investor/financial/nfil-audio-earnings-call-q1fy-2026-27.mp3.mp3 This intimation is also being made available on the Company's website at www.nfil.in. Request you to take the aforesaid information on record.
Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for Q1 of FY 2026-27
Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026
Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026
Board Meeting Outcome for August 05, 2026
Outcome of Board Meeting held on August 05, 2026: 1) Unaudited Standalone and Consolidated Financial Results and 2) Capital expenditure of INR 90 crores for establishing adoption capacities to progress products forming part of Advanced Materials portfolio, from lab scale to commercial scale qualification
Navin Fluorine International Ltd
About
Navin Fluorine International Ltd. is a leading specialty chemicals manufacturer headquartered in Mumbai, India, with a core focus on fluorine chemistry. Established as part of the Padmanabh Mafatlal Group, the company engages in the development, manufacturing, and export of a range of fluorochemicals, specialty chemicals, and contract research & manufacturing services (CRAMS).
Navin Fluorine’s product portfolio spans refrigerant gases, inorganic fluorides, specialty fluorochemicals, and high-performance products with critical applications in pharmaceuticals, agrochemicals, life sciences, and industrial sectors.
Supported by advanced R&D centers and manufacturing facilities in Surat, Dahej, Dewas, and Navi Mumbai, Navin Fluorine has built a global customer base across North America, Europe, and Asia. The company emphasizes sustainable practices, operational excellence, and safe chemical handling in compliance with global quality and regulatory standards.
Business Model & Strategy
Navin Fluorine generates revenue through the production and sale of specialty fluorochemicals, bulk fluorides, refrigerant gases, and custom synthesis services. Its business is broadly organized into three segments: specialty chemicals, inorganic fluorides, and CRAMS (Contract Research and Manufacturing Services). The specialty chemicals division, including high-value-added fluorine derivatives, contributes significantly to margins, driven by strong downstream demand from pharmaceuticals and agrochemicals.
Navin Fluorine's growth strategy leverages expanding global footprints, capacity augmentation at its Dahej and Dewas facilities, and investments in R&D innovation to move up the value chain. Strategic partnerships with international customers and a focus on import substitution further underpin its revenue streams. Long-term contracts, strong compliance, and a move towards high-margin fluorinated intermediates and new-age applications (battery materials, electronic chemicals) serve as key growth vectors.
Management Overview
12 MembersMr.Vishad Padmanabh Mafatlal
Executive Director-Chairperson related to PromoterMr.Sunilbhai Siddharthbhai Lalbhai
Non-Executive - Non Independent DirectorMr.Atul Kumar Srivastava
Non-Executive - Independent DirectorMr.Ashok Sinha
Non-Executive - Independent DirectorMr.Sujal Anil Shah
Non-Executive - Independent DirectorMrs.Apurva Purohit
Non-Executive - Independent DirectorMr.Sudhir Ramchandra Deo
Non-Executive - Non Independent DirectorMr.Abhijit Jagdish Joshi
Non-Executive - Independent DirectorMr.Nitin Ganpati Kulkarni
Executive Director-MDMr.Basant Kumar Bansal
Chief Financial OfficerMr.Partha Roychowdhury
Interim Chief Financial OfficerNirajMankad
Company Secretary & Compliance OfficerAwards & Recognition
4 Awards- Received the Gold rating in EcoVadis ESG evaluation (2024)
- Included in India's 'Best Companies to Work For – Chemicals Sector' (2024, Great Place To Work Institute)
- Recognized for Operational Excellence at the 2024 FICCI Chemicals Awards
- Recipient of the National Safety Award (2023), Ministry of Labour & Employment, India
Market Information
Company Timeline
57+ Years of Excellence | 8 Major Milestones
Company incorporated as part of the Mafatlal Group
Commissioned first refrigerant gases plant in Surat
Listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE)
Entered CRAMS business for global life sciences customers
Commissioned new High Performance Product (HPP) plant at Dahej
Significant capacity expansion at Dahej facility
Launched next-generation fluorination and battery chemicals initiatives
Received Gold ESG rating and major global supply contract in pharmaceutical segment
The Next Evolution
Contact Information
Registered Office
Office No. 602, Natraj by Rustomjee, Near Western Express Highway, Sir Mathuradas Vasanji Road, Andheri (East)
Tel: 022-66509999,
Fax: 022-66509800,
Email: info@nfil.in; niraj.mankad@nfil.in
Website: nfil.in
Corporate Actions
28| Purpose | Ex Date | Record Date | BC Start | BC End |
|---|---|---|---|---|
Final Dividend ₹8.60 per share | 12 Jun 2026 Friday | 12 Jun 2026 Friday | - | - |
Interim Dividend ₹6.50 per share | 07 Nov 2025 Friday | 07 Nov 2025 Friday | - | - |
Final Dividend ₹7 per share | 04 Jul 2025 Friday | 04 Jul 2025 Friday | - | - |
Interim Dividend ₹5 per share | 07 Nov 2024 Thursday | 07 Nov 2024 Thursday | - | - |
Final Dividend ₹7 per share | 05 Jul 2024 Friday | 05 Jul 2024 Friday | - | - |
Interim Dividend ₹5 per share | 10 Nov 2023 Friday | 10 Nov 2023 Friday | - | - |
Special Dividend ₹3 per share | 10 Nov 2023 Friday | 10 Nov 2023 Friday | - | - |
Final Dividend ₹7 per share | 07 Jul 2023 Friday | 07 Jul 2023 Friday | - | - |
Interim Dividend ₹5 per share | 03 Nov 2022 Thursday | 04 Nov 2022 Friday | - | - |
Final Dividend ₹6 per share | 07 Jul 2022 Thursday | 08 Jul 2022 Friday | - | - |
Interim Dividend ₹5 per share | 01 Nov 2021 Monday | 02 Nov 2021 Tuesday | - | - |
Final Dividend ₹6 per share | 09 Jul 2021 Friday | - | 13 Jul 2021 Tuesday | 16 Jul 2021 Friday |
Interim Dividend ₹5 per share | 10 Nov 2020 Tuesday | 11 Nov 2020 Wednesday | - | - |
Final Dividend ₹3 per share | 07 Aug 2020 Friday | - | 11 Aug 2020 Tuesday | 14 Aug 2020 Friday |
Interim Dividend ₹4 per share | 05 Mar 2020 Thursday | 06 Mar 2020 Friday | - | - |
Interim Dividend ₹4 per share | 05 Nov 2019 Tuesday | 06 Nov 2019 Wednesday | - | - |
Final Dividend ₹4 per share | 07 Jun 2019 Friday | - | 11 Jun 2019 Tuesday | 14 Jun 2019 Friday |
Interim Dividend ₹3.80 per share | 14 Nov 2018 Wednesday | 15 Nov 2018 Thursday | - | - |
Special Dividend ₹3 per share | 13 Jul 2018 Friday | - | 17 Jul 2018 Tuesday | 20 Jul 2018 Friday |
Final Dividend ₹3.60 per share | 13 Jul 2018 Friday | - | 17 Jul 2018 Tuesday | 20 Jul 2018 Friday |
Interim Dividend ₹3.40 per share | 08 Nov 2017 Wednesday | 09 Nov 2017 Thursday | - | - |
Stock Split From Rs.10/- to Rs.2/- | 19 Jul 2017 Wednesday | 20 Jul 2017 Thursday | - | - |
Final Dividend ₹13 per share | 16 Jun 2017 Friday | - | 20 Jun 2017 Tuesday | 23 Jun 2017 Friday |
Interim Dividend ₹11 per share | 04 Nov 2016 Friday | 07 Nov 2016 Monday | - | - |
Special Dividend ₹7.50 per share | 04 Nov 2016 Friday | 07 Nov 2016 Monday | - | - |
Final Dividend ₹11 per share | 15 Jul 2016 Friday | - | 19 Jul 2016 Tuesday | 22 Jul 2016 Friday |
Interim Dividend ₹10 per share | 06 Nov 2015 Friday | 09 Nov 2015 Monday | - | - |
Final Dividend ₹8.50 per share | 19 Jun 2015 Friday | - | 23 Jun 2015 Tuesday | 26 Jun 2015 Friday |
₹44,295 Cr.
₹8,655
₹8,776 / 4,499
56.01
₹774.91
11.14
₹154.18
₹2.00
0.17 %
Manage Ratio
FINANCIALS
| Annual Results | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | - | - | - | 1,030 | 1,095 | 1,258 | 1,493 | 2,113 | 2,121 | 2,393 | 3,379 | 3,720 |
| Expenses | - | - | - | 806 | 837 | 916 | 1,148 | 1,617 | 1,837 | 2,013 | 2,499 | 2,677 |
| Profit | - | - | - | 149 | 409 | 258 | 263 | 375 | 271 | 289 | 664 | 790 |
| Tax | - | - | - | 77 | -143.56 | 111 | 81 | 121 | 65 | 91 | 210 | 247 |
| EPS | - | - | - | 30 | 83 | 52 | 53 | 76 | 55 | 58 | 131 | 47.45 |
| Ratios | - |
Cash Flow
Consolidated Figures in Rs. Crores
| Annual Balance Sheet | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | - |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | - | - | - | 1,307 | 1,629 | 1,897 | 2,385 | 3,529 | 4,377 | 4,830 | 6,379 | - |
| Equity And Liabilities | - | - | - | 1,307 | 1,629 | 1,897 | 2,385 | 3,529 | 4,377 | 4,830 | 6,379 | - |
Shareholding Pattern
Numbers in Percentages
| Quarterly SHP Announcement Date | Mar 2016 12 Apr '16 | Mar 2017 31 Mar '17 | Mar 2018 31 Mar '18 | Mar 2019 09 Apr '19 | Mar 2020 28 Apr '20 | Mar 2021 20 Apr '21 | Mar 2022 12 May '22 | Mar 2023 17 Apr '23 | Mar 2024 18 Apr '24 | Mar 2025 21 Apr '25 | Mar 2026 20 Apr '26 | - |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Goverments | - | - | - | - | - | - | - | - | - | - | - | - |
| Promoter And Promoter Group | - | - | - | 31.04% | 30.51% | 30.22% | 29.70% | 28.81% | 28.81% | 28.44% | 27.11% | - |
| Non Institutions | - | - | - | 34.88% | 31.84% | 28.86% | 28.51% | 26.77% | 27.01% | 21.36% | 21.49% | - |
| FII | - | - | - | - | - | - | - | 19.58% | 15.57% | 20.16% | 23.78% | - |
| DII | - | - | - | - | - | - | - | 24.84% | 28.61% | 30.04% | 27.62% | - |
| Total | - | - | - | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | - |
Navin Fluorine International Ltd
Navin Fluorine International Ltd
Navin Fluorine International Ltd. is a leading specialty chemicals manufacturer headquartered in Mumbai, India, with a core focus on fluorine chemistry. Established as part of the Padmanabh Mafatlal Group, the company engages in the development, manufacturing, and export of a range of fluorochemicals, specialty chemicals, and contract research & manufacturing services (CRAMS).
Navin Fluorine’s product portfolio spans refrigerant gases, inorganic fluorides, specialty fluorochemicals, and high-performance products with critical applications in pharmaceuticals, agrochemicals, life sciences, and industrial sectors.
Supported by advanced R&D centers and manufacturing facilities in Surat, Dahej, Dewas, and Navi Mumbai, Navin Fluorine has built a global customer base across North America, Europe, and Asia. The company emphasizes sustainable practices, operational excellence, and safe chemical handling in compliance with global quality and regulatory standards.
Navin Fluorine generates revenue through the production and sale of specialty fluorochemicals, bulk fluorides, refrigerant gases, and custom synthesis services. Its business is broadly organized into three segments: specialty chemicals, inorganic fluorides, and CRAMS (Contract Research and Manufacturing Services). The specialty chemicals division, including high-value-added fluorine derivatives, contributes significantly to margins, driven by strong downstream demand from pharmaceuticals and agrochemicals.
Navin Fluorine's growth strategy leverages expanding global footprints, capacity augmentation at its Dahej and Dewas facilities, and investments in R&D innovation to move up the value chain. Strategic partnerships with international customers and a focus on import substitution further underpin its revenue streams. Long-term contracts, strong compliance, and a move towards high-margin fluorinated intermediates and new-age applications (battery materials, electronic chemicals) serve as key growth vectors.
Received the Gold rating in EcoVadis ESG evaluation (2024)
Included in India's 'Best Companies to Work For – Chemicals Sector' (2024, Great Place To Work Institute)
Recognized for Operational Excellence at the 2024 FICCI Chemicals Awards
Recipient of the National Safety Award (2023), Ministry of Labour & Employment, India
Company incorporated as part of the Mafatlal Group
Commissioned first refrigerant gases plant in Surat
Listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE)
Entered CRAMS business for global life sciences customers
Commissioned new High Performance Product (HPP) plant at Dahej
Significant capacity expansion at Dahej facility
Launched next-generation fluorination and battery chemicals initiatives
Received Gold ESG rating and major global supply contract in pharmaceutical segment
Peer Comparison
| S.No. | Company Name | CMP (₹) | Market Cap (₹ Cr) | Div Yld (%) | NP Qtr (₹ Cr) | Qtr Profit Var (%) | Sales Qtr (₹ Cr) | Qtr Sales Var (%) | ROCE (%) | ROE (%) | Book Value (₹) | EPS TTM (₹) | TTMPE Ratio (₹) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Not Found Data | |||||||||||||
Coming Soon
Heatmap View
Premium Feature| Company | CMP (₹) | MCap (₹ Cr) | EPS TTM (₹) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Not Found Data | |||||||||||||
Financial Ratios
Premium Feature| Company Name | P/E (TTM) | EPS (₹) | D/E | NPM | GPM | ROE (%) | ROCE (%) | P/B | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Not Found Data | |||||||||||||
Coming Soon